A detailed history of Next Century Growth Investors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Next Century Growth Investors LLC holds 236,830 shares of CSTL stock, worth $6.75 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
236,830
Previous 219,473 7.91%
Holding current value
$6.75 Million
Previous $4.86 Million 6.05%
% of portfolio
0.45%
Previous 0.43%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.84 - $24.94 $327,005 - $432,883
17,357 Added 7.91%
236,830 $5.16 Million
Q1 2024

May 14, 2024

BUY
$18.06 - $25.3 $100,901 - $141,351
5,587 Added 2.61%
219,473 $4.86 Million
Q4 2023

Feb 14, 2024

BUY
$12.19 - $22.43 $2.61 Million - $4.8 Million
213,886 New
213,886 $4.62 Million
Q2 2022

Aug 12, 2022

SELL
$16.0 - $45.99 $8.62 Million - $24.8 Million
-538,673 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$33.17 - $46.98 $7.66 Million - $10.8 Million
230,829 Added 74.98%
538,673 $24.2 Million
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $1.27 Million - $2.19 Million
32,402 Added 11.76%
307,844 $13.2 Million
Q3 2021

Nov 12, 2021

SELL
$60.13 - $77.6 $382,005 - $492,992
-6,353 Reduced 2.25%
275,442 $18.3 Million
Q2 2021

Aug 13, 2021

SELL
$50.07 - $76.78 $1.83 Million - $2.81 Million
-36,644 Reduced 11.51%
281,795 $20.7 Million
Q1 2021

May 14, 2021

SELL
$58.92 - $97.33 $1.91 Million - $3.15 Million
-32,370 Reduced 9.23%
318,439 $21.8 Million
Q4 2020

Feb 12, 2021

BUY
$43.6 - $73.05 $3.28 Million - $5.49 Million
75,155 Added 27.26%
350,809 $23.6 Million
Q3 2020

Nov 13, 2020

BUY
$38.47 - $52.03 $2.37 Million - $3.21 Million
61,729 Added 28.86%
275,654 $14.2 Million
Q2 2020

Aug 14, 2020

BUY
$27.28 - $43.01 $3.44 Million - $5.42 Million
126,104 Added 143.59%
213,925 $8.06 Million
Q1 2020

May 14, 2020

BUY
$23.08 - $35.53 $2.03 Million - $3.12 Million
87,821 New
87,821 $2.62 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $750M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.